Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

Nanopore sequencing to reveal the origins of circulating immune DNA in cancer: presentation

Monday, March 4, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: The presentation titled 'Nanopore sequencing to reveal the origins of circulating immune DNA in cancer' was delivered by Dr. Ben Berman at CNAPS 2024. It emphasizes the potential of nanopore sequencing technology in understanding the origins of immune DNA related to cancer. This innovative approach may enhance cancer diagnostics and treatment strategies.
Price reaction · baseline $20.8 (2024-03-01 close) · hit pre-market · 3 other VNRX headline(s) in the window, move may be shared
day 0 close
-2.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • Presentation highlights innovative use of nanopore sequencing.
  • Focus on understanding circulating immune DNA in cancer.
  • Presented by a qualified expert in bioinformatics.

Full Press Release Details

Presentation title: “Nanopore sequencing to reveal the origins of circulating immune DNA in cancer.”
Presented at CNAPS 2024
Presented by Ben Berman, PhD, Principal Bioinformatician, Volition, Associate Professor, Hebrew University of Jerusalem

Related Articles

• Press Releases Data Showing the Prognostic Value of its Nu.Q® Cancer Test
• Poster & Publications Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

Data Showing the Prognostic Value of its Nu.Q® Cancer Test

Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What was the main focus of the presentation?

The presentation focused on nanopore sequencing's role in revealing the origins of circulating immune DNA in cancer.

Who presented at CNAPS 2024?

Dr. Ben Berman, a Principal Bioinformatician at Volition, presented at CNAPS 2024.

What technology was discussed in the presentation?

The presentation discussed the innovative use of nanopore sequencing technology.

What is the significance of circulating immune DNA?

Circulating immune DNA is significant for understanding cancer diagnostics and treatment strategies.

ShareAdd on Google
Tags: VNRX Viatris Investor Conferences Healthcare nanopore sequencing immune DNA cancer diagnostics CNAPS 2024
Last updated: Mar 4, 2024

Biotech snapshot

Cash runway
$3M liquidity · $2M/mo burn
~1 mo
High dilution risk